In the present study, the low levels of some of the pro-inflammatory molecules detected in type 2 diabetes patients compared to those without diabetes can be explained by the fact that some of the patients with diabetes were receiving insulin therapy, which might affect the local expression of inflammatory molecules [43, 55]. This evidence concerns the gene INS and type 2 diabetes mellitus.